Guwahati: This groundbreaking procedure was led by a team of expert Neuro Spine Surgeons, Dr. Shameem Ahmed and Dr. Deep ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

This is the story of Anna Barile and her son Simone Del Vecchio. Anna accompanied her son to Albania for dental treatment.

Older adults are more prone to conditions that necessitate heart valve replacement or repair, such as calcific aortic ...

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...

Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk ...

[b]ecause aortic stenosis has a higher mortality […] management looks to be implying that doctors could be prioritizing lower mortality patients over higher mortality ones - which we struggle to ...

During the surgery Harri's heart sustained a slight tear causing him to have an acute ischemic stroke resulting in damage to his brain cells. He had lost the ability to talk, walk and couldn't move ...

Lilly’s muvalaplin is the first oral drug to show positive Phase II findings for Lp(a) reduction, eliciting up to an 86% drop ...

University Hospital Galway is the first hospital in the country to use a new biological aortic heart valve, putting it at the ...

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for ...

Two North Belfast sisters are sharing their experience of coronary heart disease in their twenties to highlight the gender ...